Danish biotechnology company Bavarian Nordic said on Monday the European Commission had given permission for its Imvanex vaccine to be marketed as protection against monkeypox, as recommended last week by the European Medicines Agency.
Bavarian Nordic s shares jumped as much as 18% on Monday after the Danish firm reported encouraging data from its COVID-19 vaccine candidate, which is set to move to human trials shortly.. | March 12, 2021